Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox checked   Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person:  For row 11: Based on a total of 313,960,336 common shares of the Issuer, par value US$0.00025 per share ("Common Shares") outstanding as of September 30, 2025 according to the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person:  For row 11: Based on a total of 313,960,336 Common Shares outstanding as of September 30, 2025 according to the Issuer.


SCHEDULE 13G



 
Shenglong Zou ("Mr. Zou")
 
Signature:/s/ Shenglong Zou
Name/Title:Shenglong Zou
Date:11/14/2025
 
Vantage Point Global Limited ("Vantage Point")
 
Signature:/s/ Shenglong Zou
Name/Title:Shenglong Zou/Director
Date:11/14/2025
Exhibit Information

Exhibit A: Joint Filing Agreement

 

Exhibit A

 

Joint Filing Agreement

 

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13G referred to below) on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Shares, par value US$0.00025 per share, of Xunlei Limited, a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

 

[Remainder of this page has been left intentionally blank.]

 

 

 

SIGNATURE

 

IN WITNESS WHEREOF, the undersigned hereby execute this Agreement as November 14, 2025.

 

Shenglong Zou   /s/ Shenglong Zou
   
Vantage Point Global Limited   By: /s/ Shenglong Zou  
  Name: Shenglong Zou  
  Title: Director  

 

[Signature Page to Joint Filing Agreement Attached to Schedule 13G/A]